Bharat Biotech
Strengthening Global Health: India’s Strategic Vaccine Collaboration in the Netherlands
In a major development for global health, particularly in vaccine production, Union Health Secretary Shri Apurva Chandra recently toured the… Read More
Vaccine Against Chikungunya in Making
A new weapon against the debilitating infection of Chikungunya could soon be in the offing. A multi-country Phase II/III clinical… Read More
Here’s How Much Bharat Biotech’s Covaxin Will Cost
India’s first indigenous vaccine, Covaxin, will be sold at Rs 600 to state governments, and Rs 1200 to private hospitals,… Read More
Nasal COVID-19 Vaccine could Soon be a Reality
In a significant development, Bharat Biotech has sought Drug Controller General India's (DCGI) approval to conduct nasal COVID-19 vaccine trials… Read More
Indigenous Indian COVID-19 Vaccines in Global Race to End the Pandemic
W ith the announcement of COVAXIN by Bharat Biotech and ZyCov-D Vaccine by Zydus Cadila the proverbial silver line in… Read More
New project to develop human monoclonal antibodies for neutralizing SARS-CoV-2
The Council of Scientific and Industrial Research (CSIR), through its New Millennium Indian Technology Leadership Initiative (NMITLI) program, has approved… Read More